BACE1 and Alzheimer disease: Serving as the primordial and rate-determining enzyme in the generation of Aβ (Willem et al., 2009), and given its increased expression in the brains of elderly individuals and AD patients (Yang et al., 2003; Fukumoto et al., 2004), BACE1 has become a pivotal target for the prevention and treatment of AD.